Last Update Time:
12-Mar-2025 16:00:00
ISIN:
INE027H01010
Sector:
Healthcare
Symbol:
MAXHEALTH
Max Healthcare Institute Limited
₹989.00
₹5.70
(0.58%)
▲
Prev. Close
₹983.30
Open
₹994.80
Close
₹989.75
Range
₹939.55 - ₹1,038.45
High
₹995.00
Low
₹960.00
Ind. Close
₹0.00
VWAP
₹977.86
The current stock price of Max Healthcare Institute Limited is ₹989.00, with a target price range between ₹939.55 and ₹1,038.45. The stock has experienced a price change of ₹5.70 (0.58%), reflecting recent market volatility.
Today's opening price was ₹994.80, while the previous close stood at ₹983.30.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Max Healthcare Institute Limited Price Chart
Max Healthcare Institute Limited Pre Open Market Overview: 12-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 994.8
- Previous Close Price: 983.3
- Change: 11.50%
- Total Traded Volume: 3,482
- Total Buy Quantity: 19,284
- Total Sell Quantity: 8,606
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 983.20 | 10.00 | 0.00 |
| 983.30 | 151.00 | 0.00 |
| 987.85 | 79.00 | 0.00 |
| 988.20 | 125.00 | 0.00 |
| 992.00 | 100.00 | 0.00 |
| 994.80 | 0.00 | 431.00 |
| 994.90 | 0.00 | 252.00 |
| 994.95 | 0.00 | 164.00 |
| 995.95 | 0.00 | 15.00 |
| 996.95 | 0.00 | 16.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 19284
Total Sell Quantity: 8606
Shareholding Patterns of Max Healthcare Institute Limited
Key Trade Statistics of Max Healthcare Institute Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 22.39 |
| Traded Value (₹ Cr.) | 218.99 |
| Total Market Cap (₹ Cr.) | 96,144.85 |
| Free Float Market Cap (₹ Cr.) | 73,300.93 |
| Impact cost | 0.04 |
| Quantity Traded | 2,239,455.00 |
| Deliverable Quantity | 1,548,385.00 |
| % of Quantity to Traded | 69.14 |
| Security VaR | 15.15 |
| Index VaR | N/A |
| VaR Margin | 15.15 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 18.65 |
| Face Value | 10 |
Key Price Statistics of Max Healthcare Institute Limited
The 52-week high for Max Healthcare Institute Limited was ₹1,227.95, recorded on 08-Jan-2025. On the other hand, the 52-week low stands at ₹719.45, with the lowest value recorded on 18-Mar-2024.
The upper band for trading is ₹1,081.60, and the lower band is ₹885.00. The price band is No Band%.
The stock's daily volatility stands at 2.35, while the annualized volatility is 44.90. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (08-Jan-2025) | 1,227.95 |
| 52 Week Low (18-Mar-2024) | 719.45 |
| Upper Band | 1,081.60 |
| Lower Band | 885.00 |
| Price Band (%) | No Band |
| Daily Volatility | 2.35 |
| Annualised Volatility | 44.90 |
| Tick Size | 0.05 |
Key Securities Statistics of Max Healthcare Institute Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 21-Aug-2020 |
| Adjusted P/E | 90.15 |
| Symbol P/E | 94.79 |
| Index | NIFTY MIDCAP 50 |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Basic Industry | Hospital |
Security Status of Max Healthcare Institute Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Max Healthcare Institute Limited
| Subject | Date |
|---|---|
| Outcome of Board Meeting | 12-Mar-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 27-Feb-2025 |
| General Updates | 26-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 24-Feb-2025 |
| Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | 18-Feb-2025 |
| Change in Management | 18-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 14-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 11-Feb-2025 |
Corporate Actions of Max Healthcare Institute Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Dividend - Rs 1.5 Per Share | 23-Aug-2024 |
| 10 | Dividend - Re 1 Per Share | 08-Sep-2023 |
Board Meetings of Max Healthcare Institute Limited
Financial Results of Max Healthcare Institute Limited
Company Directory of Max Healthcare Institute Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| N/A | Head Office/ Corporate Office | 2nd Floor, Capital Cyberscape,, Sector - 59, Gurugram, Haryana - 122011 | N/A |
| N/A | Registered Office | 401, 4th Floor, Man Excellenza, S. V. Road, Vile Parle (West), Mumbai Mumbai | MUMBAI |
| N/A | Transfer Agent | Link Intime India Private Limited Noble Heights, 1st Floor, Plot No. NH 2, LSC C-1 Block, Near Savitri Market, Janakpuri, | NEW DELHI |
Insider Trading of Max Healthcare Institute Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Abhay Soi | 6880 | Buy |
| 7(2) | Kayak Investments Holding Pte. Ltd. | 6880 | Sell |
| 7(2) | Kayak Investments Holding Pte. Ltd. | 91858199597 | Sell |
| 7(2) | Kayak Investments Holding Pte. Ltd. | 32968167984 | Sell |
| 7(2) | Ruchi Mahajan | 6799150 | Sell |
| 7(2) | BalKishan Sharma | 5265000 | Sell |
| 7(2) | BalKishan Sharma | 10299600 | Sell |
| 7(2) | Poonam Das | 33837967 | Pledge |
| 7(2) | Manish Luthra | 1590000 | Sell |
| 7(2) | Sandeep Tanwar | 12444064 | Sell |
| 7(2) | Nidhi M Dev | 1590015 | Sell |
| 7(2) | Sandeep Budhiraja | 11791300 | Sell |
| 7(2) | Sandeep Dogra | 8840352 | Sell |
| 7(2) | Vinita Jha | 1904450 | Sell |
| 7(2) | Sandeep Dogra | 2053300 | Pledge Invoke |
| 7(2) | Sandeep Dogra | 5940090 | Pledge Invoke |
| 7(2) | Arpita Mukherjee | 1885000 | Sell |
| 7(2) | Sandeep Dogra | 13319197 | Pledge Invoke |
| 7(2) | Pawan Datta | 393100 | Buy |
| 7(2) | Vishal Lathwal | 336810 | Buy |
Annual Reports of Max Healthcare Institute Limited
| Company | From Year | To Year | Att. |
|---|---|---|---|
| Max Healthcare Institute Limited | 2023 | 2024 | |
| Max Healthcare Institute Limited | 2022 | 2023 | |
| Max Healthcare Institute Limited | 2021 | 2022 | |
| Max Healthcare Institute Limited | 2020 | 2021 |
Investor Complaints of Max Healthcare Institute Limited
Event Calendar of Max Healthcare Institute Limited
| Purpose | Details |
|---|---|
| Fund Raising | To consider Fund Raising |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
| Financial Results | To consider and approve the Un-Audited Financial Results for the period ended December 31, 2020 |
| Financial Results | To consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2021 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
| Financial Results | To consider and approve the unaudited Consolidated and Standalone Financial Results for the quarter and half year ended September 30, 2021 |
| Financial Results | To consider and approve the unaudited Consolidated and Standalone Financial Results for the quarter and nine months ended December 31, 2021 |
| Financial Results | To consider and approve the unaudited Consolidated and Standalone Financial Results for the quarter and nine months ended December 31, 2021 |
| Financial results | Max Healthcare Institute Limited has informed the Exchange about Board Meeting to be held on 25-May-2022 to consider financial statements for the period ended March 2022 |
| Fund Raising | Pursuant to regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our letter dated January 24, 2023, we wish to inform that it is proposed to consider issuance of non-convertible debentures for raising of funds on private placement basis, in one or more tranches / series, at the Board Meeting scheduled to be held on Thursday, February 02, 2023. |
| Financial Results | meeting of Board of Directors of the Company is scheduled to be held on Thursday, February 02, 2023, inter-alia, to consider and approve Unaudited Standalone and Consolidate Financial Results of the Company for the quarter and nine months ended December 31, 2022. |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2023 and recommend final dividend, if any. |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2024 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Max Healthcare Institute Limited
Voting Results of Max Healthcare Institute Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 20-SEP-2024 | AGM | Adoption of Audited Standalone Financial Statements for the financial year 2023-24 |
| 20-SEP-2024 | AGM | Ratification of remuneration payable to Cost Auditors for the financial year 2024-25 |
| 20-SEP-2024 | AGM | Appointment of Dr. Pranav C. Mehta as an Independent Director of the Company |
| 20-SEP-2024 | AGM | Appointment of director in place of Mr. Narayan K. Seshadri, who retires by rotation and being eligible offers himself for re-appointment |
| 20-SEP-2024 | AGM | Declaration of final Dividend of Rs. 1.5 (i.e. 15%) per equity share of face value of Rs. 10 each |
| 20-SEP-2024 | AGM | Adoption of Audited Consolidated Financial Statements for the financial year 2023-24 |
| 05-MAY-2024 | Postal Ballot | Re-appointment of Mr. Michael Thomas Neeb as an Independent Director of the Company |
| 05-MAY-2024 | Postal Ballot | Re-appointment of Mr. Mahendra Gumanmalji Lodha as an Independent Director of the Company |
| 27-SEP-2023 | AGM | Adoption of Audited Standalone Financial Statements for the financial year ended March 31, 2023 together with the reports of board of directors and auditor￢ﾀﾙs thereon |
| 27-SEP-2023 | AGM | Ratification of remuneration payable to Cost Auditors for the financial year 2023-24 |
| 27-SEP-2023 | AGM | Approval for alteration in Articles of Association of the Company |
| 27-SEP-2023 | AGM | One-time Performance Bonus to Mr. Abhay Soi, Chairman and Managing Director |
| 27-SEP-2023 | AGM | Increase in remuneration of Non-Executive Directors (including Independent Directors) |
| 27-SEP-2023 | AGM | Payment of remuneration to Ms. Amrita Gangotra as an Independent Director of the Company |
| 27-SEP-2023 | AGM | Appointment of Ms. Amrita Gangotra as an Independent Director of the Company for a term of 5 (five) consecutive years |
| 27-SEP-2023 | AGM | Fixation of tenure of Mr. Anil Kumar Bhatnagar, Non-Executive Director for 3 (three) years |
| 27-SEP-2023 | AGM | Appointment of Director in place of Mr. Anil Kumar Bhatnagar, who retires by rotation and being eligible, offers himself for re-appointment |
| 27-SEP-2023 | AGM | Declaration of final Dividend of ￂ 1 (i.e. 10%) per equity share of face value of ￂ 10 each |
| 27-SEP-2023 | AGM | Adoption of Audited Consolidated Financial Statements for the financial year ended March 31, 2023 together with the report of the auditor￢ﾀﾙs thereon |
| 14-AUG-2023 | Postal Ballot | Appointment of Mr. Narayan K. Seshadri as Non-Executive and Non-Independent Director |
FAQs on Max Healthcare Institute Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.